CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: association study and meta-analysis.

Studies in the past have clearly established that cytotoxic T-lymphocyte antigen-4 (CTLA4) is a susceptible gene for Graves' disease (GD). However, association studies between the CTLA4 exon-1 +49A/G polymorphism and the risk of developing Graves' ophthalmopathy (GO) in GD patients have revealed conflicting results. In this study, associations of two CTLA4 polymorphisms (+49A/G and CT60) with GD risk and GO susceptibility in GD patients were investigated in a Chinese population. In addition, a meta-analysis was performed to better assess the purported association between the +49A/G polymorphism and GO susceptibility in GD patients. Our results demonstrated that both the +49A/G and CT60 polymorphisms were associated with GD susceptibility in the Chinese population. No significant association with GO susceptibility in GD patients was confirmed regardless of which polymorphism was tested individually. Similarly, the meta-analysis results provided minimal evidence about the role of the +49A/G polymorphism and GO risk in GD patients. Interestingly, haplotypic analysis demonstrated different scenarios concerning the role of CTLA4 in GO susceptibility in the Chinese GD patients. We found that the +49A-CT60G haplotype was marginally statistically associated with the increased risk of GO in GD patients (OR = 1.63, 95%CI 1.00-2.64, p = 0.05). In conclusion, our results suggested that CTLA4 might be involved in the susceptibility to GD in the Chinese population. Although neither +49A/G nor CT60 polymorphism was associated with the risk of GO in GD patients, the haplotypic analysis provided some evidence about its role in GO susceptibility in the Chinese GD patients. We suggest that more association studies recruiting haplotypic analysis should be performed to investigate the role of CTLA4 gene in GO susceptibility in patients from different nations.